Trial · NCT07895082
Quanduzhong Capsules for Primary Osteoporosis
NCT07895082, Phase 3, Enrolling by invitation, Shanghai University of Traditional Chinese Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Quanduzhong Capsules for Primary Osteoporosis. Trials, record NCT07895082. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895082
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Quanduzhong Capsules for Primary Osteoporosis
- NCT number
- NCT07895082
- Status
- Enrolling by invitation
- Phases
- Phase 3
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Shanghai University of Traditional Chinese Medicine
- Conditions
- Primary Osteoporosis
- Interventions
- Quan Duzhong Capsules, Quan Duzhong Capsule Placebo
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in bone mineral density (BMD) of the lumbar spine (L1-L4) | Baseline and 6 months | BMD of the lumbar spine (L1-L4) measured by dual-energy X-ray absorptiometry (DXA). The absolute change and percentage change from baseline will be calculated. |
| Secondary | Change in Serum Calcium | Baseline and 6 months | Serum calcium measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum Phosphorus | Baseline and 6 months | Serum phosphorus measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in muscle strength | Baseline and 6 months | Muscle strength is assessed by study-specific measurements during the study. |
| Secondary | Change in incidence of falls | Baseline and 6 months | the number and incidence of falls should be recorded during the study. |
| Secondary | Change in 25-Hydroxyvitamin D | Baseline and 6 months | Serum 25-hydroxyvitamin D measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Parathyroid Hormone (PTH) | Baseline and 6 months | Serum parathyroid hormone (PTH) measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum P1NP | Baseline and 6 months | Serum procollagen type 1 N-terminal propeptide (P1NP), a bone formation marker, measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum CTX | Baseline and 6 months | Serum C-terminal telopeptide of type I collagen (CTX), a bone resorption marker, measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum Osteocalcin | Baseline and 6 months | Serum osteocalcin measured by laboratory tests. Change from baseline will be calculated. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895082
GET https://conductscience.org/api/trials/v1/NCT07895082/registered